Lupin has informed that, as approved by the Nomination and Remuneration Committee of the Company on December 13, 2023, the Company granted stock options aggregating 258695 to its employees and those of its subsidiaries, at the exercise price of 2.00 each, details of which are enclosed. It has informed that upon vesting, one stock option entitles the grantee to subscribe to one equity share of the Company of ? 2.00 each. The vesting schedule of stock options will be 25%:25%:25%:25% over four years upon completion of one year from the date of grant.
The above information is a part of company’s filings submitted to BSE.
